The DOI matches its Crossref record; 118 of the 121 references it cites were found in a registry or an index.
The Anti-Cancer Effect of Quercetin: Molecular Implications in Cancer Metabolism
Open accessAbstract
Cancer is a problem with worldwide importance and is the second leading cause of death globally. Cancer cells reprogram their metabolism to support their uncontrolled expansion by increasing biomass (anabolic metabolism—glycolysis) at the expense of their energy (bioenergetics-mitochondrial function) requirements. In this aspect, metabolic reprogramming stands out as a key biological process in understanding the conversion of a normal cell into a neoplastic precursor. Quercetin is the major representative of the flavonoid subclass of flavonols. Quercetin is ubiquitously present in fruits and vegetables, being one of the most common dietary flavonols in the western diet. The anti-cancer effects of quercetin include its ability to promote the loss of cell viability, apoptosis and autophagy through the modulation of PI3K/Akt/mTOR, Wnt/β-catenin, and MAPK/ERK1/2 pathways. In this review, we discuss the role of quercetin in cancer metabolism, addressing specifically its ability to target molecular pathways involved in glucose metabolism and mitochondrial function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Quercetin is a natural product and nonspecific kinase inhibitor that targets PI3K/AKT pathway modules, as well as BCL-2, insulin/IGF-1, and HIF-1α SCAP networks components, and is senolytic, possibly as a consequence of its inhibitory effects on multiple SCAP genes (i.e. PI3K and other kinases).14,17,18”
From Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability (2023) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · cited 4×
“In contrast, cancer cells frequently utilize glycolysis even in the presence of sufficient amounts of oxygen [6].”
BackgroundInfluentialmTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 1×
“In addition, Akt activates mTORC1/2 [29], which regulates the downstream signaling of protein and lipid synthesis, metabolism, cell survival and apoptosis [29–31].”
BackgroundEstimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553 · cited 1×
“6 million deaths caused by cancer disease [1].”
BackgroundThe Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · cited 2×
“availability, cancer cells undergo competitions for nutrients with other types of cells, which are part of their microenvironments [7,8].”
BackgroundWhy Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784 · cited 1×
“Likewise, it has been described that a change in glucose metabolism called the “Warbug Effect” occurs in cancer cells [14,15].”
BackgroundOtto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331 · cited 1×
“availability, cancer cells undergo competitions for nutrients with other types of cells, which are part of their microenvironments [7,8].”
BackgroundMetabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057 · cited 2×
“Specifically, glucose-6-phosphate and fructose-6-phosphate, glyceraldehyde-3-phosphate, and 3-phosphoglycerate are glycolytic intermediates that are substrates for nucleotide, aminoacid and lipid biosynthesis [21].”
BackgroundFundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013 · cited 1×
“In this sense, in cancer cells, glycolysis generates high levels of carbon-rich metabolic intermediates that could be utilized as precursors for de novo synthesis of nucleotides, lipids, or amino acids [20,21].”
BackgroundThe role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
Muz, B., de la Puente, P., Azab, F., & Azab, A. K. (2015) · Hypoxia · doi:10.2147/hp.s93413 · Cited by 2,066 · cited 1×
“This switch in cell metabolism is beneficial for cancer progression and resistance to therapy [6,16,17].”
BackgroundPI3K/AKT/mTOR Pathway in Angiogenesis
Karar, J., & Maity, A. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00051 · Cited by 1,461
Phenol-Explorer: an online comprehensive database on polyphenol contents in foods
Neveu, V., Perez-Jimenez, J., Vos, F., Crespy, V., du Chaffaut, L., Mennen, L., Knox, C., Eisner, R., Cruz, J., Wishart, D., et al. (2010) · Database · doi:10.1093/database/bap024 · Cited by 1,439
HIF-1: upstream and downstream of cancer metabolism
Semenza, G. L. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,372 · cited 1×
“In cancer cells, metabolic reprogramming is regulated by several pathways, including the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt), which promotes an increased glucose uptake and glycolysis [22,23].”
BackgroundPI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting
Thorpe, L. M., Yuzugullu, H., & Zhao, J. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3860 · Cited by 1,345 · cited 1×
“PI3K transduces the signal across messengers that activate Akt, and thus completely active, the PI3K/Akt pathway regulates cell angiogenesis, metabolism, growth, proliferation, survival, protein synthesis, transcription and apoptosis [24,25].”
BackgroundTargeting metabolic transformation for cancer therapy
Tennant, D. A., Durán, R. V., & Gottlieb, E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2817 · Cited by 1,059 · cited 1×
“In cancer cells, metabolic reprogramming is regulated by several pathways, including the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt), which promotes an increased glucose uptake and glycolysis [22,23].”
BackgroundHemmings, B. A., & Restuccia, D. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011189 · Cited by 1,049
Targeting cellular metabolism to improve cancer therapeutics
Zhao, Y., Butler, E. B., & Tan, M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.60 · Cited by 989
Takahashi, H., & Shibuya, M. (2005) · Clinical Science · doi:10.1042/cs20040370 · Cited by 953 · cited 1×
“PI3K/Akt pathway activation concludes in metalloproteinase (MMP) synthesis, promoting cell invasion [111].”
BackgroundCancer Cell Metabolism: One Hallmark, Many Faces
Cantor, J. R., & Sabatini, D. M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0345 · Cited by 947 · cited 1×
“The activated mTOR directly or indirectly stimulates metabolic reprogramming by activating key transcription factors, such as c-Myc, cyclin D, and hypoxia-inducible transcription factor 1 alpha (HIF-1α), even under normoxic conditions [32].”
BackgroundHypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology
Semenza, G. L. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02090-1 · Cited by 930
Rothwell, J. A., Perez-Jimenez, J., Neveu, V., Medina-Remon, A., M'Hiri, N., Garcia-Lobato, P., Manach, C., Knox, C., Eisner, R., Wishart, D. S., et al. (2013) · Database · doi:10.1093/database/bat070 · Cited by 881
Lu, H., Forbes, R. A., & Verma, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202487200 · Cited by 837 · cited 1×
“In addition, HIF-1α up-regulates the vascular endothelial growth factor (VEGF), erythropoietin (EPO), glucose transporter 1 (GLUT1), and glycolytic enzymes genes under normal O2 conditions [36,37].”
BackgroundHypoxia and Metabolic Adaptation of Cancer Cells
Eales, K. L., Hollinshead, K. E. R., & Tennant, D. A. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.50 · Cited by 724 · cited 1×
“This switch in cell metabolism is beneficial for cancer progression and resistance to therapy [6,16,17].”
BackgroundBuccal micronucleus cytome assay
Thomas, P., Holland, N., Bolognesi, C., Kirsch-Volders, M., Bonassi, S., Zeiger, E., Knasmueller, S., & Fenech, M. (2009) · Nature Protocols · doi:10.1038/nprot.2009.53 · Cited by 638
Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo
Hashemzaei, M., Far, A. D., Yari, A., Heravi, R. E., Tabrizian, K., Taghdisi, S. M., Sadegh, S. E., Tsarouhas, K., Kouretas, D., Tzanakakis, G., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5766 · Cited by 520
Roberts, D. J., & Miyamoto, S. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.173 · Cited by 504 · cited 1×
“Akt activation increases glycolysis by promoting hexokinase 2, which directly interact with the mitochondrial pore to prevent the release of apoptotic proteins [28].”
BackgroundSrivastava, S., Somasagara, R. R., Hegde, M., Nishana, M., Tadi, S. K., Srivastava, M., Choudhary, B., & Raghavan, S. C. (2016) · Scientific Reports · doi:10.1038/srep24049 · Cited by 483 · cited 1×
“Quercetin (6 doses of 1 mg/kg orally, every third day) increased the DNA fragmentation in tumor tissues and reduced the tumor volume of breast adenocarcinoma in mice [73].”
BackgroundMetabolism of stromal and immune cells in health and disease
Ghesquière, B., Wong, B. W., Kuchnio, A., & Carmeliet, P. (2014) · Nature · doi:10.1038/nature13312 · Cited by 451 · cited 1×
“Therefore, uncontrollable cell proliferation and tumor formation induce a change in metabolic requirements, as well as in nutrient and oxygen cellular availability [9,10], which promotes metabolic reprogramming [11–13].”
BackgroundPI3K signaling in cancer: beyond AKT
Lien, E. C., Dibble, C. C., & Toker, A. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.02.007 · Cited by 451
Dietary Intake and Major Food Sources of Polyphenols in Finnish Adults3
Ovaskainen, M.-L., Törrönen, R., Koponen, J. M., Sinkko, H., Hellström, J., Reinivuo, H., & Mattila, P. (2008) · The Journal of Nutrition · doi:10.1093/jn/138.3.562 · Cited by 434
Moving targets: Emerging roles for MMPs in cancer progression and metastasis
Shay, G., Lynch, C. C., & Fingleton, B. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.019 · Cited by 424 · cited 1×
“environment for the tumor’s metastatic process [112].”
Dietary intake of 337 polyphenols in French adults
Pérez-Jiménez, J., Fezeu, L., Touvier, M., Arnault, N., Manach, C., Hercberg, S., Galan, P., & Scalbert, A. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.007096 · Cited by 424 · cited 1×
“According to the US Department of Health and Human Services, the average daily intake of QUE in humans is about 25 mg [41], a value which is also supported by French and Finnish studies [42,43].”
ResultPhosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer
Koundouros, N., & Poulogiannis, G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00160 · Cited by 415
Nagao, A., Kobayashi, M., Koyasu, S., Chow, C. C. T., & Harada, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020238 · Cited by 402
Benjamin, D., Robay, D., Hindupur, S. K., Pohlmann, J., Colombi, M., El-Shemerly, M. Y., Maira, S.-M., Moroni, C., Lane, H. A., & Hall, M. N. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.043 · Cited by 401 · cited 1×
“These transporters excrete the glycolytic end-products, lactate and H+, and prevent the intracellular acidification-induced cell death of highly glycolytic cancer cells [96].”
BackgroundEffects of low dose quercetin: Cancer cell‐specific inhibition of cell cycle progression
Jeong, J., An, J. Y., Kwon, Y. T., Rhee, J. G., & Lee, Y. J. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21977 · Cited by 380 · cited 2×
“This was mediated by down-regulating cyclin B1 and cyclin-dependent kinase 1 (CDK1), essential components of G2/M cell cycle progression and by inducing phosphorylation of the retinoblastoma tumor suppressor protein, pRb [59].”
BackgroundWang, K., Liu, R., Li, J., Mao, J., Lei, Y., Wu, J., Zeng, J., Zhang, T., Wu, H., Chen, L., et al. (2011) · Autophagy · doi:10.4161/auto.7.9.15863 · Cited by 378 · cited 1×
“Quercetin also has the ability to induce protective autophagy in gastric and breast cancer cells by inactivating the Akt-mTOR pathway [64,74] and HIF-1α signaling [74].”
BackgroundMetabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
Sun, L., Suo, C., Li, S.-T., Zhang, H., & Gao, P. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.005 · Cited by 363
The AMP-activated protein kinase (AMPK) and cancer: Many faces of a metabolic regulator
Faubert, B., Vincent, E. E., Poffenberger, M. C., & Jones, R. G. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.01.018 · Cited by 354 · cited 9×
“However, by including the bioenergetics perspective, inhibiting both glycolytic and mitochondrial pathways for ATP production could be a more efficient approach to kill cancer cells.”
BackgroundInfluentialRAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression
Rezatabar, S., Karimian, A., Rameshknia, V., Parsian, H., Majidinia, M., Kopi, T. A., Bishayee, A., Sadeghinia, A., Yousefi, M., Monirialamdari, M., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28334 · Cited by 340 · cited 1×
“These transcription factor molecules, AP-1 and NF-κB, are involved in the neoplastic transformation and development of cancer and are regulated by upstream kinases, including MAPKs signaling pathways [81,82].”
BackgroundThe Akt pathway in oncology therapy and beyond (Review)
Nitulescu, G., Van De Venter, M., Nitulescu, G., Ungurianu, A., Juzenas, P., Peng, Q., Olaru, O., Grădinaru, D., Tsatsakis, A., Tsoukalas, D., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4597 · Cited by 328 · cited 1×
“AMPK controls glucose and lipid metabolism by sensing changes in nutrient and extracellular energy levels [26].”
BackgroundKawabata, K., Mukai, R., & Ishisaka, A. (2015) · Food & Function · doi:10.1039/c4fo01178c · Cited by 326 · cited 4×
“β-glycosidases in the intestine catalyze the hydrolysis of glycosidic bonds before being absorbed into the enterocytes [54,55].”
BackgroundInfluentialPotential health effects of the dietary flavonol quercetin.
Hertog, M. G. L., & Hollman, P. C. H. (1996) · PubMed · Cited by 312
Jia, L., Huang, S., Yin, X., Zan, Y., Guo, Y., & Han, L. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.027 · Cited by 304 · cited 11×
“Quercetin (30 μM) also has been shown to decrease LDH-A protein levels in breast cancer, MDA-MB-231, and MCF-7 cells [64].”
BackgroundInfluentialThe Warburg Effect: Why and How Do Cancer Cells Activate Glycolysis in the Presence of Oxygen?
Lopez-Lazaro, M. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008783961932 · Cited by 285 · cited 1×
“Likewise, it has been described that a change in glucose metabolism called the “Warbug Effect” occurs in cancer cells [14,15].”
BackgroundAerobic glycolysis and high level of lactate in cancer metabolism and microenvironment
Jiang, B. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.02.003 · Cited by 268 · cited 1×
“The acidic microenvironment produced by increased glycolysis in tumor cells provides a favorable microenvironment for tumor metastasis [109].”
BackgroundCancer, Oxidative Stress, and Metastasis
Gill, J. G., Piskounova, E., & Morrison, S. J. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030791 · Cited by 266 · cited 1×
“Oxidative stress has been linked to the hyper-activation of signaling pathways for cell survival, proliferation and migration, as well as metabolic adaptations of tumor microenvironment [67].”
BackgroundGranato, M., Rizzello, C., Gilardini Montani, M. S., Cuomo, L., Vitillo, M., Santarelli, R., Gonnella, R., D'Orazi, G., Faggioni, A., & Cirone, M. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.12.011 · Cited by 261 · cited 3×
“Moreover, QUE decreased the release of interleukin-6 (IL-6) and IL-10, and the phosphorylation/activation of the signal transducer and activator of transcription 3 (STAT3)Tyr705/Ser727 [62].”
BackgroundInfluentialEndogenous and exogenous mediators of quercetin bioavailability
Guo, Y., & Bruno, R. S. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.10.008 · Cited by 256 · cited 2×
“β-glycosidases in the intestine catalyze the hydrolysis of glycosidic bonds before being absorbed into the enterocytes [54,55].”
BackgroundHIF-1 in cancer therapy: two decade long story of a transcription factor
Soni, S., & Padwad, Y. S. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1301680 · Cited by 251 · cited 1×
“In fact, HIF-1α is the primary driver of increased glycolysis and lactate production during hypoxia [35].”
BackgroundMYC and tumor metabolism: chicken and egg
Dejure, F. R., & Eilers, M. (2017) · The EMBO Journal · doi:10.15252/embj.201796438 · Cited by 240 · cited 7×
“Besides promoting a high glycolytic rate, HIF-1α activation also inhibits oxidative phosphorylation by up-regulating genes, such as pyruvate dehydrogenase kinase 1 (PDK1) and LDH-A.”
BackgroundInfluentialMetabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer
Lien, E. C., Lyssiotis, C. A., & Cantley, L. C. (2016) · Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_3 · Cited by 212
The effect of flavonoids on aerobic glycolysis and growth of tumor cells.
Suolinna, E.-M., Buchsbaum, R., & Racker, E. (1975) · PubMed · Cited by 210
Oxygen availability and metabolic reprogramming in cancer
Xie, H., & Simon, M. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.799973 · Cited by 206
Quercetin and Derivatives: Useful Tools in Inflammation and Pain Management
Carullo, G., Cappello, A. R., Frattaruolo, L., Badolato, M., Armentano, B., & Aiello, F. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0186 · Cited by 206
Tewari, D., Nabavi, S. F., Nabavi, S. M., Sureda, A., Farooqi, A. A., Atanasov, A. G., Vacca, R. A., Sethi, G., & Bishayee, A. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.09.014 · Cited by 205 · cited 1×
“These transcription factor molecules, AP-1 and NF-κB, are involved in the neoplastic transformation and development of cancer and are regulated by upstream kinases, including MAPKs signaling pathways [81,82].”
BackgroundLee, K. W., Kang, N. J., Heo, Y.-S., Rogozin, E. A., Pugliese, A., Hwang, M. K., Bowden, G. T., Bode, A. M., Lee, H. J., & Dong, Z. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3140 · Cited by 194 · cited 3×
“In addition, QUE inhibited mitogen-activated protein kinase kinase (MEK1) and Raf1 kinase activities, as well as the subsequently attenuated TPA-induced phosphorylation of ERK/p90 ribosomal S6 kinase in JB6 P cells [80].”
BackgroundInfluentialLang, D. R., & Racker, E. (1974) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(74)90002-4 · Cited by 193
Morris, M. E., & Felmlee, M. A. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9035-6 · Cited by 192 · cited 1×
“It is suggested that QUE alters glucose metabolism by inhibiting monocarboxylate transporter (MCT) activity [97,99].”
BackgroundRothwell, J. A., Urpi-Sarda, M., Boto-Ordonez, M., Knox, C., Llorach, R., Eisner, R., Cruz, J., Neveu, V., Wishart, D., Manach, C., et al. (2012) · Database · doi:10.1093/database/bas031 · Cited by 188
Liu, Y., Gong, W., Yang, Z. Y., Zhou, X. S., Gong, C., Zhang, T. R., Wei, X., Ma, D., Ye, F., & Gao, Q. L. (2017) · Apoptosis · doi:10.1007/s10495-016-1334-2 · Cited by 186 · cited 2×
“Quercetin has been shown to promote mitochondrial-mediated apoptosis and protective autophagy at the same time, by inducing endoplasmic reticulum stress via the p-STAT3/Bcl-2 axis in CAOV3 human ovarian cancer cells [72].”
BackgroundIzumi, H., Takahashi, M., Uramoto, H., Nakayama, Y., Oyama, T., Wang, K., Sasaguri, Y., Nishizawa, S., & Kohno, K. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01908.x · Cited by 179 · cited 2×
“It is suggested that QUE alters glucose metabolism by inhibiting monocarboxylate transporter (MCT) activity [97,99].”
BackgroundKim, H., Moon, J. Y., Ahn, K. S., & Cho, S. K. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/596496 · Cited by 170 · cited 1×
“It has been proposed that QUE induced protective autophagy in U373MG cells, as pretreatment with chloroquine, an autophagy inhibitor, strongly augmented apoptosis in these cells [71].”
BackgroundXintaropoulou, C., Ward, C., Wise, A., Marston, H., Turnbull, A., & Langdon, S. P. (2015) · Oncotarget · doi:10.18632/oncotarget.4499 · Cited by 159 · cited 5×
“Quercetin (0–200 μM, 24 h incubation [61] and 0–300 μM, 5 days incubation [58]) inhibited the cell viability of colon cancer cell lines HCT-15 and RKO [61] and inhibited the proliferation of the breast cancer cell lines MCF-7, MDA-MB-231, HBL100 and BT549, and the ovarian cancer cell lines, OVCAR5, TOV112D, OVCAR3 and…”
InfluentialLei, C.-S., Hou, Y.-C., Pai, M., Lin, M., & Yeh, S. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.09.011 · Cited by 156 · cited 2×
“In combined treatments with QUE and SN-38 (active metabolite of irinotecan, inhibitor of DNA topoisomerase I), the cell viability, percentage of apoptosis, and β-catenin protein levels were comparable to those after treatment with high-dose SN-38 alone in the AGS human gastric adenocarcinoma cell line [76].”
BackgroundResultCancer’s Fuel Choice: New Flavors for a Picky Eater
DeNicola, G. M., & Cantley, L. C. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.018 · Cited by 151 · cited 1×
“In addition, HIF-1α up-regulates the vascular endothelial growth factor (VEGF), erythropoietin (EPO), glucose transporter 1 (GLUT1), and glycolytic enzymes genes under normal O2 conditions [36,37].”
BackgroundTumour microenvironment factors shaping the cancer metabolism landscape
Anastasiou, D. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.412 · Cited by 144 · cited 1×
“Therefore, uncontrollable cell proliferation and tumor formation induce a change in metabolic requirements, as well as in nutrient and oxygen cellular availability [9,10], which promotes metabolic reprogramming [11–13].”
BackgroundAnti-Cancer Effects of Green Tea Polyphenols Against Prostate Cancer
Miyata, Y., Shida, Y., Hakariya, T., & Sakai, H. (2019) · Molecules · doi:10.3390/molecules24010193 · Cited by 136 · cited 1×
“In preclinical studies, green tea polyphenols have shown anti-cancer and cancer preventative effects in a number of malignancies [118].”
BackgroundThe PI3K-PKB/Akt PathwayPreprint
Hemmings, B. A., & Restuccia, D. F. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a026609 · Cited by 131 · cited 1×
“PI3K transduces the signal across messengers that activate Akt, and thus completely active, the PI3K/Akt pathway regulates cell angiogenesis, metabolism, growth, proliferation, survival, protein synthesis, transcription and apoptosis [24,25].”
BackgroundInhibition of lactate transport and glycolysis in Ehrlich ascites tumor cells by bioflavonoids
Belt, J. A., Thomas, J. A., Buchsbaum, R., & Racker, E. (1979) · Biochemistry · doi:10.1021/bi00583a011 · Cited by 128
Erdoğan, S., Turkekul, K., Dıbırdık, İ., Doğanlar, O., Doğanlar, Z. B., Bılır, A., & Öktem, G. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.061 · Cited by 127 · cited 3×
“The combined use of the two agents further reduced cell proliferation compared to the individual use of each [77].”
BackgroundThe Glycolytic Inhibitor 2-Deoxyglucose Activates Multiple Prosurvival Pathways through IGF1R
Zhong, D., Xiong, L., Liu, T., Liu, X., Liu, X., Chen, J., Sun, S., Khuri, F. R., Zong, Y., Zhou, Q., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.005280 · Cited by 126 · cited 1×
“Although 2-DG has the ability to target glycolysis, its potential to be used as an anti-tumor drug is limited because 2-DG also stimulates the PI3K/Akt, MEK/ERK and insulin-like growth factor 1 receptor (IGF1R) pathways, promoting a survival signal in tumor cell lines [104].”
BackgroundDesideri, E., Vegliante, R., & Ciriolo, M. R. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.023 · Cited by 124 · cited 1×
“In this way, the entrance of pyruvate into the TCA cycle is decreased [38].”
BackgroundEffects of quercetin on the proliferation of breast cancer cells and expression of survivin in vitro
Deng, X., Song, H., ZHOU, Y.-F., YUAN, G.-Y., & ZHENG, F.-J. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1285 · Cited by 117 · cited 3×
“This was mediated by down-regulating cyclin B1 and cyclin-dependent kinase 1 (CDK1), essential components of G2/M cell cycle progression and by inducing phosphorylation of the retinoblastoma tumor suppressor protein, pRb [59].”
BackgroundQuercetin in our diet: From potent mutagen to probable anticarcinogen
Stavrić, B. (1994) · Clinical Biochemistry · doi:10.1016/0009-9120(94)90025-6 · Cited by 117 · cited 1×
“According to the US Department of Health and Human Services, the average daily intake of QUE in humans is about 25 mg [41], a value which is also supported by French and Finnish studies [42,43].”
ResultQuercetin inhibits a large panel of kinases implicated in cancer cell biology
Kiss (2010) · International Journal of Oncology · doi:10.3892/ijo.2010.890 · Cited by 116 · cited 2×
“Quercetin displayed strong anti-mitotic activity by decreasing the activity of several kinases involved in the control of mitotic processes by more than 80%, such as Aurora kinases A and B, MET kinase, NIMA-related kinases (NEK4 and NEK9), PAKs (p21-activated kinases) and platelet-derived growth factor (PDGF) [66].”
BackgroundDirect Inhibition of the Hexose Transporter GLUT1 by Tyrosine Kinase Inhibitors
Vera, J. C., Reyes, A. M., Velásquez, F. V., Rivas, C. I., Zhang, R. H., Strobel, P., Slebe, J. C., Núñez-Alarcón, J. A., & Golde, D. W. (2000) · Biochemistry · doi:10.1021/bi001660j · Cited by 109 · cited 1×
“In acute myeloblastic leukemia HL60 cells, 50 μM of QUE effectively inhibited about 70% of the GLUT1 mediated methylglucose uptake [101].”
BackgroundCarrasco‐Pozo, C., Tan, K. N., Reyes‐Farias, M., Jara, N., Ngo, S. T., García‐Díaz, D. F., Llanos, P., Cires, M. J., & Borges, K. (2016) · Redox Biology · doi:10.1016/j.redox.2016.08.007 · Cited by 109
Self-citationQuercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells
Shang, H., Lu, H., Lee, C., Chiang, H., Chu, Y., Chen, A., Lin, Y., & Chung, J. (2018) · Environmental Toxicology · doi:10.1002/tox.22623 · Cited by 106
Wang, P., Heber, D., & Henning, S. M. (2012) · Food & Function · doi:10.1039/c2fo10254d · Cited by 101
Quercetin, an Artificial Regulator of the High Aerobic Glycolysis of Tumor Cells 1 2
Suolinna, E.-M., Lang, D., & Racker, E. (1974) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/53.5.1515 · Cited by 100
Amorim, R., Pinheiro, C. M., Miranda‐Gonçalves, V., Pereira, H., Moyer, M. P., Preto, A., & Baltazar, F. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.015 · Cited by 96 · cited 5×
“Quercetin (0–200 μM, 24 h incubation [61] and 0–300 μM, 5 days incubation [58]) inhibited the cell viability of colon cancer cell lines HCT-15 and RKO [61] and inhibited the proliferation of the breast cancer cell lines MCF-7, MDA-MB-231, HBL100 and BT549, and the ovarian cancer cell lines, OVCAR5, TOV112D, OVCAR3 and…”
BackgroundInfluentialEffect of quercetin on the proliferation of the human ovarian cancer cell line SKOV-3 in vitro
Ming-xin, R., Deng, X., AI, F., YUAN, G.-Y., & Song, H. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2536 · Cited by 93 · cited 3×
“This was mediated by down-regulating cyclin B1 and cyclin-dependent kinase 1 (CDK1), essential components of G2/M cell cycle progression and by inducing phosphorylation of the retinoblastoma tumor suppressor protein, pRb [59].”
BackgroundDysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells
Marbaniang, C., & Kma, L. (2018) · PubMed Central · doi:10.22034/apjcp.2018.19.9.2377 · Cited by 92 · cited 1×
“Major oncogenes, such as c-Myc, and HIF-1α, are reported to be master inducers of cancer glycolysis through direct or indirect transactivation of cancer glycolytic genes [33].”
BackgroundTakei, Y., Kadomatsu, K., Goto, T., & Muramatsu, T. (2006) · Cancer · doi:10.1002/cncr.22068 · Cited by 92 · cited 1×
“An antisense oligonucleotide and siRNA targeting the MK suppress tumor formation in vitro as well as in nude mice [78,79].”
BackgroundQuercetin as a novel activator of L‐type Ca2+channels in rat tail artery smooth muscle cells
Saponara, S., Sgaragli, G., & Fusi, F. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704631 · Cited by 92
Modica-Napolitano, J. S., & Weissig, V. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817394 · Cited by 86 · cited 1×
“Recently, it has been proposed that in malignant cells, the metabolic shift to glycolysis is induced by their greater need for glucose metabolites (used for biomass production), instead of any specific impairment of the mitochondrial respiratory function [87].”
BackgroundWang, P., Heber, D., & Henning, S. M. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.661514 · Cited by 86
CK2 and PI3K are direct molecular targets of quercetin in chronic lymphocytic leukaemia
Russo, M., Milito, A., Spagnuolo, C., Carbone, V., Rosén, A., Minasi, P., Lauria, F., & Russo, G. L. (2017) · Oncotarget · doi:10.18632/oncotarget.17246 · Cited by 80 · cited 1×
“In fact, recently, QUE has been shown to directly inhibit PI3K enzymatic activity [98].”
BackgroundMa, Y., Yao, C., Liu, H., Yu, F., Lin, J., Lu, K.-W., Liao, C., Chueh, F., & Chung, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.8584 · Cited by 79
Dihal, A. A., van der Woude, H., Hendriksen, P. J. M., Charif, H., Dekker, L. J. M., IJsselstijn, L., de Boer, V. C. J., Alink, G. M., Burgers, P. C., Rietjens, I. M. C. M., et al. (2007) · PROTEOMICS · doi:10.1002/pmic.200700364 · Cited by 76 · cited 1×
“In the distal colon mucosa of rats supplemented with QUE (a 10 g/kg diet for 11 weeks), the MAPK pathway was downregulated and tumor suppressor genes, such as PTEN, Tp53, and Msh2, were upregulated [83].”
MethodMaurya, A. K., & Vinayak, M. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.990574 · Cited by 76 · cited 3×
“Decreased Akt levels, an essential mediator of PI3K signaling, and p85α phosphorylation, an essential component in PI3K activation, altered PI3K signaling in Dalton’s lymphoma mice treated with QUE [91].”
BackgroundKale, A. A., Gawande, S., Kotwal, S. D., Netke, S. P., Roomi, W., Ivanov, V. O., Niedzwiecki, A., & Rath, M. (2009) · Phytotherapy Research · doi:10.1002/ptr.2899 · Cited by 74
Does GSK-3 provide a shortcut for PI3K activation of Wnt signalling?
Voskas, D., Ling, L. S., & Woodgett, J. R. (2010) · F1000 Biology Reports · doi:10.3410/b2-82 · Cited by 68
Potential of the Flavonoid Quercetin to Prevent and Treat Cancer – Current Status of Research
Neuwirthová, J., Gál, B., Smilek, P., & Urbánková, P. (2018) · Klinicka onkologie · doi:10.14735/amko2018184 · Cited by 68
Flavones as Colorectal Cancer Chemopreventive Agents—Phenol-O-Methylation Enhances Efficacy
Cai, H., Sale, S., Schmid, R., Britton, R. G., Brown, K., Steward, W. P., & Gescher, A. J. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0081 · Cited by 64 · cited 3×
“This compound also showed potent cancer cell growth inhibition for A549, H157, H460, 1792, Hop62 and 1299 cells [84].”
BackgroundInfluentialMaurya, A. K., & Vinayak, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160686 · Cited by 63 · cited 2×
“As QUE prevented the alterations induced by H2O2 similar to the PI3k inhibitor PI-103, it is suggested that QUE attenuates PI3K/Akt pathway with a similar mechanism to PI-103 [69].”
BackgroundThe role of ATPase in glycolysis of Ehrlich ascites tumor cells.
Racker, E., Johnson, J. H., & Blackwell, M. T. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32721-2 · Cited by 59
Altundağ, E. M., Yılmaz, A. M., Koçtürk, S., Taga, Y., & Yalçın, A. S. (2017) · Nutrition and Cancer · doi:10.1080/01635581.2018.1380208 · Cited by 57
Lozanovski, V. J., Houben, P., Hinz, U., Hackert, T., Herr, I., & Schemmer, P. (2014) · Trials · doi:10.1186/1745-6215-15-204 · Cited by 55
Torres, G., Baltiérrez‐Hoyos, R., Andrade‐Jorge, E., Villa‐Treviño, S., Trujillo-Ferrara, J. G., & Vásquez-Garzón, V. R. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2734976 · Cited by 55
Carullo, G., Perri, M., Manetti, F., Aiello, F., Caroleo, M. C., & Cione, E. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.05.018 · Cited by 54
Yin, H., Ma, J., Han, J., Li, M., & Shang, J. (2019) · PeerJ · doi:10.7717/peerj.6665 · Cited by 50 · cited 1×
“Isoquercitrin’s bioavailability is only 5% of that observed with QUE, and in the gut, it is rapidly metabolized to QUE by β-glucosidases [102].”
BackgroundIn vitro effects of some flavonoids and phenolic acids on human pyruvate kinase isoenzyme M2
Aslan, E., Güler, Ç., & Adem, Ş. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1022173 · Cited by 49 · cited 1×
“24 μM, inhibited the activity of recombinant human pyruvate kinase isoenzyme M2 (PKM2), a key control point of glycolysis, by 50% [100].”
BackgroundHamidullah, Kumar, R., Saini, K. S., Kumar, A., Kumar, S., Ramakrishna, E., Maurya, R., Konwar, R., & Chattopadhyay, N. (2015) · Biochimie · doi:10.1016/j.biochi.2015.10.012 · Cited by 48 · cited 2×
“Quercetin-6-C-β-d-glucopyranoside (QCG) is a cis-glycoside natural analog of QUE [85].”
BackgroundQuercetin/Oleic Acid-Based G-Protein-Coupled Receptor 40 Ligands as New Insulin Secretion Modulators
Badolato, M., Carullo, G., Perri, M., Cione, E., Manetti, F., Gioia, M. L. D., Brizzi, A., Caroleo, M. C., & Aiello, F. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0113 · Cited by 48
Targeting Glucose Metabolism: An Emerging Concept for Anticancer Therapy
Madhok, B., Yeluri, S., Perry, S., Hughes, T. A., & Jayne, D. G. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181e84dec · Cited by 46 · cited 1×
“Although multiple glycolytic inhibitors and mitochondria-targeted compounds have been developed, only a few have progressed to clinical trials, due to selectivity, efficacy and safety limitations [88,89].”
BackgroundInhibition of Midkine Suppresses Prostate Cancer CD133 + Stem Cell Growth and Migration
Erdoğan, S., Doğanlar, Z. B., Doğanlar, O., Turkekul, K., & Serttas, R. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2017.04.019 · Cited by 40
Sturza, A., Pavel, I. Z., Ancușa, S., Danciu, C., Dehelean, C. A., Duicu, O., & Muntean, D. M. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3296-x · Cited by 38 · cited 1×
“Quercetin has been shown to induce mitochondrial dysfunction, reducing the basal and maximal respiration and the ATP-production liked to oxygen consumption in acute myeloblastic leukemia HL60 cells [90].”
BackgroundNoori–Daloii, M. R., Momeny, M., Yousefi, M., Golsaz‐Shirazi, F., Yaseri, M., Motamed, N., Kazemialiakbar, N., & Hashemi, S. (2010) · Medical Oncology · doi:10.1007/s12032-010-9603-3 · Cited by 37 · cited 1×
“17%, without causing cytotoxicity [63].”
Role of the RB-Interacting Proteins in Stem Cell Biology
Mushtaq, M., Gaza, H. V., & Kashuba, E. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.04.002 · Cited by 30 · cited 1×
“Hypophosphorylated Rb binds to and sequesters the transcription factor E2F1, an essential transcriptional factor required for the expression of cell proliferation-associated genes, resulting in cell cycle arrest at the G1 phase [65].”
BackgroundYarahmadi, A., Khademi, F., Mostafavi-Pour, Z., & Zal, F. (2018) · Nutrition and Cancer · doi:10.1080/01635581.2018.1470654 · Cited by 30
de Blas, E., Estañ, M. C., de Frutos, M. D. C. G., Ramos, J., Boyano-Adánez, M. D. C., & Aller, P. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0345-y · Cited by 20 · cited 4×
“Quercetin (5–40 μM for 24 h incubation) concentration dependently decreased cell viability and caused very low apoptotic effect in acute myeloblastic leukemia HL60 cells [103].”
BackgroundMethodInfluentialPreferential Inhibition by Quercetin of Mitogen-Stimulated Thymocyte Glucose Transport 2
Hume, D. A., Dean, J. H., Weidemann, M. J., & Ferber, E. (1979) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/62.5.1243 · Cited by 18
Protein synthesis in dextran sulfate-treated ascites tumor cells.
McCoy, G. D., & Racker, E. (1976) · PubMed · Cited by 16
Csepregi, R. K., Temesfői, V., Sali, N., Poór, M., Needs, P. W., Kroon, P. A., & Kőszegi, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092670 · Cited by 15 · cited 1×
“Quercetin-3′-sulfate is the major metabolite of QUE found in human blood plasma and has been shown to decrease glucose and ATP levels in HepG2 cells, probably by interfering with GLUT2-mediated glucose uptake [86].”
BackgroundHenning, S. M., Aronson, W. J., Wang, P., Wang, J., Lee, R., Grojean, E. M., Ly, A., Hsu, M., Heber, D., & Li, Z. (2017) · The FASEB Journal · doi:10.1096/fasebj.31.1_supplement.148.8 · Cited by 2
Cited by
Blevins, H. M., Xu, Y., Biby, S., & Zhang, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.879021 · Cited by 587
Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy
Dehelean, C. A., Marcovici, I., Soica, C., Mioc, M., Coricovac, D., Iurciuc, S., Cretu, O. M., & Pinzaru, I. (2021) · Molecules · doi:10.3390/molecules26041109 · Cited by 502
“Quercetin, a major representative of the flavonoid subclass of flavonols, is abundantly present in fruits and vegetables [36].”
BackgroundHealth Benefits of Quercetin in Age-Related Diseases
Deepika, & Maurya, P. K. (2022) · Molecules · doi:10.3390/molecules27082498 · Cited by 447
“It is also known to have anti-diabetic, anticarcinogenic, and antimicrobial properties [35].”
BackgroundNambiar, A., Kellogg, D., Justice, J., Goros, M., Gelfond, J., Pascual, R., Hashmi, S., Masternak, M., Prata, L., LeBrasseur, N., et al. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104481 · Cited by 298
Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets
Asgharian, P., Tazekand, A. P., Hosseini, K., Forouhandeh, H., Ghasemnejad, T., Ranjbar, M., Hasan, M., Kumar, M., Beirami, S. M., Tarhriz, V., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02677-w · Cited by 274
Metadata
- Authors
- Reyes-Farias, M., & Carrasco-Pozo, C.
- Affiliations
- Department of Endocrinology and Nutrition, Germans Trias i Pujol Research Institute, 08916 Barcelona, Spain
- Discovery Biology, Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111, Australia
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-06-28
- Volume
- 20
- Issue
- 13
- Pages
- 3177
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6651418
- OpenAlex
- W2955896228
- Cited by
- 689
- References
- 121
- Citations by year
- 2026: 70 · 2025: 122 · 2024: 118 · 2023: 145 · 2022: 126 · 2021: 67 · 2020: 35 · 2019: 5
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Griffith Research Online (submittedVersion, cc-by)
- Funders
- Comisión Nacional de Investigación Científica y Tecnológica
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Flavonoids in Medical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
- Keywords
- quercetin, flavonoids, cancer metabolism, metabolic reprogramming, glycolysis, mitochondrial function, glucose metabolism, apoptosis, autophagy, PI3K/AKT/mTOR pathway, Wnt/β-catenin signaling, MAPK/ERK1/2 pathway, anticancer effects
- MeSH terms
- Animals, Antineoplastic Agents, Energy Metabolism, Humans, Neoplasms, Quercetin, Signal Transduction, Apoptosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.